[Summary] Genetic engineering pharmaceuticals, genetic engineering vaccines, and
I. Company Introduction: Beijing Tri-Prime Gene Engineering Co., Ltd. (abbreviated as: Tri-Prime Gene, stock code: 920344) is a modern biomedical technology enterprise with a registered capital of RMB 121.81 million. It is mainly engaged in the research, development, production, and sales of pharmaceutical and biotechnological products, including genetically engineered pharmaceuticals, genetically engineered vaccines, and diagnostic reagents, as well as related technology trade and technical consulting services. Established in 1992, Tri-Prime Gene is an enterprise named after proprietary genetic engineering technology in China, co-founded by Mr. Hou Yunde, former Vice President of the Chinese Academy of Engineering, and Mr. Cheng Yongqing, one of China's earliest professional managers in high-tech entrepreneurship and venture capital. The main product of Tri-Prime Gene, recombinant human interferon α1b, is a first-class new drug of genetic engineering with independent intellectual property rights in China, used for the treatment of various viral diseases and malignant tumors. Yundesu (trade name of recombinant human interferon α1b) has established a high-quality brand for Chinese genetic drugs and created good economic and social benefits. Tri-Prime Gene has strong R&D capabilities. In 2001, its R&D center was approved by the Ministry of Personnel to establish a postdoctoral research workstation. Currently, it is developing more than ten projects, holds multiple new drugs in clinical research with international advanced level, and owns more than forty invention patents in China, the United States, and other countries. Tri-Prime Gene has successively undertaken more than ten major new drug innovation projects organized by the national and Beijing municipal levels and has obtained more than ten new drug certificates and production approvals. II. Corporate Honors: 1- 2017 National Science and Technology Award (awarded to Academician Hou Yunde of the company) 2- First Prize of National Science and Technology Progress Award (awarded to Academician Hou Yunde of the company) 3- High-tech Enterprise 4- Supporting unit of the "National Key Scientific and Technological Achievements Promotion Plan" 5- A-level Tax Credit Enterprise 6- Beijing Engineering Technology Research Center 7- National Life Science and Technology Talent Training Base 8- Postdoctoral Research Workstation 9- Beijing Patent Demonstration Unit 10- National Key New Product Certificate III. Management Team: Company Founder Hou Yunde: Education: 1955 - Graduated from Medical College of Tongji University, China; 1962 - Graduated from the USSR Academy of Medical Sciences with a Doctor of Medicine degree. Work Experience: 1985-1996: Director of the Institute of Virology, Chinese Academy of Preventive Medicine; Director of the WHO Collaborating Center for Virus Research in China; Director of the State Key Laboratory of Viral Gene Engineering; 1986-1996: Chief Scientist in Biotechnology of the High-Tech Development Plan of the National Science and Technology Commission; 1992-1998: Chairman of Beijing Tri-Prime Gene Engineering Co., Ltd.; 1998-present: Vice President of the Chinese Academy of Engineering, Academician; 2008-present: Chief Technical Officer for the Major Infectious Disease Project of the Ministry of Health. Company Founder and Chairman & General Manager Cheng Yongqing: Education: 1980-1984: Bachelor of Medicine in Pharmacy from West China University of Medical Sciences; 1988-1991: Master of Medicine in Biomedical Technology from Peking Union Medical College Graduate School; 1996-1998: Executive MBA from China Europe International Business School. Work Experience: 1984-1988: Deputy Director of Technology Development Department of Beijing Pharmaceutical Factory; 1990-1998: General Manager of Pharmaceutical and Biotechnology Division of China Science and Technology High-tech Investment Co., Ltd.; General Manager of France Pioneer International Co., Ltd.; 1992-2015: General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd.; 2015-present: Chairman and General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd. IV. Benefits: 1- Two-day weekend, social insurance plus housing fund (six insurances and one fund?) 2- Free working lunch 3- Stock options / year-end bonus 4- Trade union festival benefits, party branch activities 5- Work residence permit application 6- Free training opportunities 7- Free physical examination 8- Public rental housing application
What does Beijing Tri-Prime Gene Engineering Co., Ltd. require? Who is Tri-Prime Gene hiring? Tri-Prime Gene recruitment: 经营管理类占比最多占52.4%,其次是生物/制药/化工/环保类占28.6%. What education can get in at Tri-Prime Gene? 本科占比最多占66.7%,其次是硕士占28.6%. High education required at Tri-Prime Gene? 硕士占28.6%,博士占4.8%. Work experience required at Tri-Prime Gene? 不限占比最多占38.1%,其次是3-5年占23.8%. Where are the job locations at Tri-Prime Gene? 北京占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows